22-39134031-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_175709.5(CBX7):c.616G>A(p.Glu206Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,603,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_175709.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CBX7 | NM_175709.5 | c.616G>A | p.Glu206Lys | missense_variant | 6/6 | ENST00000216133.10 | NP_783640.1 | |
CBX7 | NM_001346743.2 | c.613G>A | p.Glu205Lys | missense_variant | 6/6 | NP_001333672.1 | ||
CBX7 | NM_001346744.2 | c.337G>A | p.Glu113Lys | missense_variant | 6/6 | NP_001333673.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CBX7 | ENST00000216133.10 | c.616G>A | p.Glu206Lys | missense_variant | 6/6 | 1 | NM_175709.5 | ENSP00000216133.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 246450Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 133482
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1451192Hom.: 0 Cov.: 31 AF XY: 0.0000194 AC XY: 14AN XY: 720452
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | The c.616G>A (p.E206K) alteration is located in exon 6 (coding exon 6) of the CBX7 gene. This alteration results from a G to A substitution at nucleotide position 616, causing the glutamic acid (E) at amino acid position 206 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at